New User? Sign Up | Sign In

Insider Trading - INGRAM ROBERT ALEXANDER

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for INGRAM ROBERT ALEXANDER
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-01-17
Sale
2017-01-19
5:53 pm
Clearside Biomedical Inc. CLSD Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Crumpler John
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Thorp Clay
10% Owner
25,301 $8.625 $218,222 1,757,719
(Indirect)
View
2017-01-17
Sale
2017-01-19
7:31 pm
Clearside Biomedical Inc. CLSD Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
Crumpler John
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Thorp Clay
10% Owner
29,656 $8.625 $255,785 2,060,514
(Indirect)
View
2017-05-22
Purchase
2017-05-24
8:18 pm
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
Crumpler John
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
10% Owner
133,333 $15 $1,999,995 3,861,797
(Indirect)
View
2017-08-25
Purchase
2017-08-29
4:37 pm
Novan Inc. NOVN INGRAM ROBERT ALEXANDER
Director
12,000 $4.567 $54,809 69,777
(Direct)
View
2018-05-21
Sale
2018-05-23
8:46 pm
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
INGRAM ROBERT ALEXANDER
Crumpler John
LEE KENNETH B JR
Reed Douglas MD
10% Owner
37,500 $51.11 $1,916,678 4,037,711
(Indirect)
View
2018-05-30
Sale
2018-06-01
6:22 pm
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
INGRAM ROBERT ALEXANDER
Crumpler John
LEE KENNETH B JR
Reed Douglas MD
10% Owner
800,000 $48 $38,400,000 3,237,711
(Indirect)
View
2018-09-28
Purchase
2018-10-01
4:34 pm
Novan Inc. NOVN INGRAM ROBERT ALEXANDER
Director
50,000 $2.84 $142,000 119,777
(Direct)
View
2018-10-22
Purchase
2018-10-24
4:18 pm
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
300,000 $5 $1,500,000 416,481
(Indirect)
View
2019-05-22
Purchase
2019-05-23
08:31 am
Novan Inc. NOVN INGRAM ROBERT ALEXANDER
Director
50,000 $2.21 $110,500 169,777
(Direct)
View
2019-11-18
Purchase
2019-11-18
4:12 pm
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
20,000 $1.45 $29,000 48,088
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-12-01
Option Award
2016-12-02
2:09 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
1,788 $5.59 4,221
(Direct)
View
2016-12-30
Option Award
2017-01-04
7:45 pm
N/A
N/A
Valeant Pharmaceuticals International Inc. VRX INGRAM ROBERT ALEXANDER
Director
1,463 $14.52 89,926
(Direct)
View
2017-01-25
Option Award
2017-01-26
4:28 pm
N/A
N/A
CREE INC CREE INGRAM ROBERT ALEXANDER
Director
867 $28.83 60,684
(Direct)
View
2017-03-02
Option Award
2017-03-02
3:07 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
1,602 $6.24 5,823
(Direct)
View
2017-03-31
Option Award
2017-04-04
5:53 pm
N/A
N/A
Valeant Pharmaceuticals International Inc. VRX INGRAM ROBERT ALEXANDER
Director
2,120 $11.03 92,046
(Direct)
View
2017-04-26
Option Award
2017-04-27
4:27 pm
N/A
N/A
CREE INC CREE INGRAM ROBERT ALEXANDER
Director
1,132 $22.07 61,816
(Direct)
View
2017-05-22
Conversion
2017-05-24
8:18 pm
N/A
N/A
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
Crumpler John
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
10% Owner
3,728,464 $0 3,861,797
(Indirect)
View
2017-05-22
Conversion
2017-05-24
8:18 pm
N/A
N/A
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
Crumpler John
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
10% Owner
212,419 $0 3,861,797
(Indirect)
View
2017-05-22
Conversion
2017-05-24
8:18 pm
N/A
N/A
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
Crumpler John
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
10% Owner
99,513 $0 3,861,797
(Indirect)
View
2017-05-22
Conversion
2017-05-24
8:18 pm
N/A
N/A
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
Crumpler John
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
10% Owner
1,318,681 $0 3,861,797
(Indirect)
View
2017-05-22
Conversion
2017-05-24
8:18 pm
N/A
N/A
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
Crumpler John
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
10% Owner
6,568,527 $0 3,861,797
(Indirect)
View
2017-05-22
Conversion
2017-05-24
8:18 pm
N/A
N/A
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
Crumpler John
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
10% Owner
2,584,959 $0 3,861,797
(Indirect)
View
2017-05-22
Conversion
2017-05-24
8:18 pm
N/A
N/A
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
Crumpler John
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
10% Owner
1,009,693 $0 3,861,797
(Indirect)
View
2017-05-24
Option Award
2017-05-25
11:48 am
2017-06-24
2027-05-24
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
30,000 $5.13 30,000
(Direct)
View
2017-06-01
Option Award
2017-06-02
4:04 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
1,941 $5.15 7,764
(Direct)
View
2017-06-05
Option Award
2017-06-07
5:56 pm
N/A
2027-06-04
Novan Inc. NOVN INGRAM ROBERT ALEXANDER
Director
34,014 $4.64 34,014
(Direct)
View
2017-08-23
Option Award
2017-08-24
4:13 pm
N/A
N/A
CREE INC CREE INGRAM ROBERT ALEXANDER
Director
1,125 $22.21 62,941
(Direct)
View
2017-09-01
Option Award
2017-09-05
11:29 am
N/A
N/A
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
3,676 $5.1 11,440
(Direct)
View
2017-09-01
Option Award
2017-09-06
4:23 pm
N/A
N/A
CREE INC CREE INGRAM ROBERT ALEXANDER
Director
7,033 $0 69,974
(Direct)
View
2017-10-18
Option Award
2017-10-20
4:20 pm
N/A
N/A
CREE INC CREE INGRAM ROBERT ALEXANDER
Director
731 $34.16 70,705
(Direct)
View
2017-12-01
Option Award
2017-12-04
3:53 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
3,690 $5.08 15,130
(Direct)
View
2017-11-30
Other
2017-12-04
5:01 pm
N/A
N/A
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
INGRAM ROBERT ALEXANDER
Crumpler John
LEE KENNETH B JR
Reed Douglas MD
10% Owner
99,513 $0 4,075,211
(Indirect)
View
2017-11-30
Other
2017-12-04
5:01 pm
N/A
N/A
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
INGRAM ROBERT ALEXANDER
Crumpler John
LEE KENNETH B JR
Reed Douglas MD
10% Owner
995 $0 4,075,211
(Indirect)
View
2018-01-24
Option Award
2018-01-26
4:17 pm
N/A
N/A
CREE INC CREE INGRAM ROBERT ALEXANDER
Director
833 $35.98 71,538
(Direct)
View
2018-03-01
Option Award
2018-03-02
2:14 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
3,772 $4.97 18,902
(Direct)
View
2018-04-25
Option Award
2018-04-27
4:41 pm
N/A
N/A
CREE INC CREE INGRAM ROBERT ALEXANDER
Director
764 $39.25 72,302
(Direct)
View
2018-06-01
Option Award
2018-06-04
2:54 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
2,916 $6.43 21,818
(Direct)
View
2018-06-04
Option Award
2018-06-07
8:51 pm
N/A
2028-06-03
Novan Inc. NOVN INGRAM ROBERT ALEXANDER
Director
20,000 $3.08 20,000
(Direct)
View
2018-06-20
Option Award
2018-06-22
09:38 am
2018-07-20
2028-06-20
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
30,000 $6.09 30,000
(Direct)
View
2018-08-15
Option Award
2018-08-16
4:19 pm
N/A
N/A
CREE INC CREE INGRAM ROBERT ALEXANDER
Director
648 $46.26 72,950
(Direct)
View
2018-08-30
Exercise
2018-08-31
4:14 pm
N/A
N/A
CREE INC CREE INGRAM ROBERT ALEXANDER
Director
4,000 $30.92 0
(Direct)
View
2018-08-30
Exercise
2018-08-31
4:14 pm
2012-09-01
2018-09-01
CREE INC CREE INGRAM ROBERT ALEXANDER
Director
4,000 $30.92 0
(Direct)
View
2018-10-17
Option Award
2018-10-18
4:19 pm
N/A
N/A
CREE INC CREE INGRAM ROBERT ALEXANDER
Director
760 $39.46 77,710
(Direct)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
52,690 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
1,683,420 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
150,612 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
4,846 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
266,481 $0 416,481
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
19,061 $0.12 416,481
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
19,061 $0.12 416,481
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
458 $5 416,481
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
1,731 $0.12 416,481
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
1,731 $0.12 416,481
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
42 $5 416,481
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
47,458 $0.12 416,481
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
47,458 $0.12 416,481
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
1,139 $5 416,481
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
4,309 $0.12 416,481
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
4,309 $0.12 416,481
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
104 $5 416,481
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
41,414 $0.12 416,481
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
41,414 $0.12 416,481
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
994 $5 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
52,690 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
42,530 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
3,862 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
4,846 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
174,699 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
13,609 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
1,044,764 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
94,874 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
149,320 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
13,558 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
40,420 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
272,107 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
24,709 $0 416,481
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:18 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
Hatteras Ventures Partners III LP
Hatteras Venture Affiliates III Lp
Hatteras Venture Partners I LP
Catalysta Ventures LLC
Venture Capital Multiplier Fund
INGRAM ROBERT ALEXANDER
LEE KENNETH B JR
Reed Douglas MD
Crumpler John
10% Owner
226,061 $0 416,481
(Indirect)
View
2019-05-29
Option Award
2019-05-31
4:21 pm
2020-05-29
2029-05-29
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
30,000 $2.91 30,000
(Direct)
View
2019-07-31
Option Award
2019-08-02
4:16 pm
N/A
2029-07-30
Novan Inc. NOVN INGRAM ROBERT ALEXANDER
Director
20,000 $2.63 20,000
(Direct)
View
2019-09-01
Option Award
2019-09-04
4:08 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
6,270 $2.99 28,088
(Direct)
View
2019-12-01
Option Award
2019-12-03
5:09 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
6,578 $2.85 54,666
(Direct)
View
2020-03-01
Option Award
2020-03-03
4:47 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
6,250 $3 60,916
(Direct)
View
2020-05-12
Option Award
2020-05-14
4:27 pm
2021-05-12
2030-05-12
BIOCRYST PHARMACEUTICALS INC BCRX INGRAM ROBERT ALEXANDER
Director
40,000 $5.41 40,000
(Direct)
View
Goto page 0, 1, Next